Cancer knows no boundaries

Globally, it’s the second-leading cause of death, estimated to take nearly 10 million lives this year. Guardant Health is working around the world to change this.

Guardant Health AMEA

In Japan alone, more than 350,000 people die from solid tumor cancers each year. To address the growing cancer burden in Asia, the Middle East, and Africa, we formed Guardant Health AMEA Inc., a joint venture with Softbank.

Led by CEO Simran Singh, Guardant Health AMEA will focus on commercializing products first in Japan, and then throughout the region.

Europe and Americas

Guardant Health currently markets its tests in 38 countries outside the United States, primarily through distributor relationships or direct contracts with hospitals. All customer samples are shipped globally to the laboratory in Redwood City, California.